Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Asahi Kasei ( (JP:3407) ) has shared an announcement.
Asahi Kasei reported stable operating income for the fiscal 2025 second quarter, with notable growth in its healthcare and domestic housing sectors, despite challenges in its materials segment. The company anticipates record-high operating income for the second consecutive year, driven by strong performance in pharmaceuticals and electronics, and plans to enhance shareholder returns through increased dividends and a share repurchase program.
The most recent analyst rating on (JP:3407) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on Asahi Kasei stock, see the JP:3407 Stock Forecast page.
More about Asahi Kasei
Asahi Kasei Corporation operates in the diversified chemicals industry, providing a wide range of products and services including pharmaceuticals, homes, and essential chemicals. The company focuses on growth in its priority businesses such as pharmaceuticals and electronics, aiming to enhance its market position.
Average Trading Volume: 4,105,651
Technical Sentiment Signal: Buy
Current Market Cap: Yen1607.3B
For an in-depth examination of 3407 stock, go to TipRanks’ Overview page.